All News
A new device for delivering drugs without needles draws inspiration from the elegant squid
Proof-of-concept experiments show the device is more efficient than other methods of delivering drugs orally, and more convenient than needles.
Read MoreSustained Viral Suppression in Multidrug-Resistant HIV With Lenacapavir at 3 Years
(MedPage Today) -- In 3-year data from the CAPELLA study, the subcutaneous, long-acting capsid inhibitor lenacapavir (Sunlenca) demonstrated sustained suppression with no emergence of resistance in h
Read MoreWhat to Know About Jay Bhattacharya, Trump's Potential NIH Pick
(MedPage Today) -- Jay Bhattacharya, MD, PhD, of Stanford University in California, has emerged as President-elect Donald Trump's top pick to lead the National Institutes of Health (NIH), according t
Read MoreMetformin, Lifestyle Changes Fail to Reduce Afib Burden
(MedPage Today) -- CHICAGO -- Metformin with or without lifestyle modification did not reduce daily atrial fibrillation (Afib) burden over standard of care for patients with implanted heart devices
Read MoreA United Front: Helping Protect Infants From RSV Lower Respiratory Tract Disease
(MedPage Today) -- The experts interviewed for this article are Sanofi's paid partners.
Read MorePotassium Binder Cuts Hyperkalemia Risk in HF Patients on Spironolactone
(MedPage Today) -- CHICAGO -- Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients with heart failure with reduced ejection f
Read MoreWhat It's Like to Win an Ig Nobel; Oxygen Company Too Big to Ban? AI Cuts Care
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Read MoreSTAT+: RFK Jr. is exploring a plan to upend Medicare’s physician payments system
The idea would reduce the role played by the American Medical Association in determining how much doctors get paid
Read MoreSacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy
(MedPage Today) -- CHICAGO -- Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving anthracycline chemotherapy in the SARAH trial.
Read MoreHoliday Gatherings After the Election Don’t Have to Be Contentious
How to avoid a contentious family holiday after the big election.
Read More